Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Expert Review of Vaccines|June 23, 2011
Neuroendocrine cancer vaccines in clinical trialsByram W BridleCytokine & Growth Factor Reviews|March 16, 2010
Combining oncolytic virotherapy and tumour vaccinationByram W Bridle, Stephen Hanson, Brian D LichtyVaccines|January 22, 2022
How Does Severe Acute Respiratory Syndrome-Coronavirus-2 Affect the Brain and Its Implications for the Vaccines Currently in UsePhilip R Oldfield, Jennifer Hibberd, Byram W BridleImmunology|June 17, 2017
Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytesKatrina E Allison, Brenda L Coomber, Byram W BridleMethods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic VaccinationJonathan G Pol, Byram W Bridle, Brian D LichtyTransplant Immunology|September 15, 2009
Steering orally induced deviation of xenogeneic immunity with exogenous cytokines in rats fed porcine proteinsByram W Bridle, Bruce N Wilkie, Anthony M Jevnikar, et al.Transplant Immunology|May 12, 2007
Deviation of xenogeneic immune response and bystander suppression in rats fed porcine blood mononuclear cellsByram W Bridle, Bruce N Wilkie, Anthony M Jevnikar, et al.International Journal of Molecular Sciences|February 11, 2023
The Potential of Dendritic-Cell-Based Vaccines to Modulate Type 3 Innate Lymphoid Cell PopulationsLily Chan, Yeganeh Mehrani, Jessica A Minott, et al.Vaccines|October 28, 2023
Dendritic Cell Vaccines Impact the Type 2 Innate Lymphoid Cell Population and Their Cytokine Generation in MiceLily Chan, Yeganeh Mehrani, Jessica A Minott, et al.Biomedicines|August 26, 2022
Tumor Temperature: Friend or Foe of Virus-Based Cancer ImmunotherapyJason P Knapp, Julia E Kakish, Byram W Bridle, et al.Pageof 9